Valeant Pharma (VRX) to Acquire Synergetics USA (SURG) for $6.50/Share + Milestones
Synergetics USA, Inc. (NASDAQ: SURG) and Valeant Pharmaceuticals International ("Valeant"), a wholly-owned subsidiary of Valeant Pharmaceuticals International, Inc. (NYSE: VRX) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
